IL6 and type 2 diabetes mellitus: Furthermore, the training interventions showed a greater effect in the reduction of fibroblast‐growth factor 21 (FGF21) and interleukin‐6 (IL‐6) in patients with CAD and T2D than in patients with CAD alone.